← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2012Last known activity
Oct 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (24 distinct, 15 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (24)
- NCT07102615OfficialPhase 4Oct 30, 2025
- NCT07102615Lead sponsorPhase 4Oct 30, 2025
- NCT07101250OfficialPhase 4Sep 15, 2025
- NCT07101250Lead sponsorPhase 4Sep 15, 2025
- NCT06291727Lead sponsorPhase 4Feb 16, 2024
- NCT05281562Overall official - principal investigatorPhase 2/Phase 3Jul 1, 2022
- NCT05281562Lead sponsorPhase 2/Phase 3Jul 1, 2022
- NCT05388929Lead sponsorPhase 4Jun 23, 2022
- NCT05388929Overall official - principal investigatorPhase 4Jun 23, 2022
- NCT05238233Lead sponsorPhase 4Apr 1, 2022
- NCT05138549Lead sponsorPhase 2/Phase 3Jan 31, 2022
- NCT05138549Overall official - principal investigatorPhase 2/Phase 3Jan 31, 2022
- NCT05023655Overall official - principal investigatorPhase 2Nov 30, 2021
- NCT05023655Lead sponsorPhase 2Nov 30, 2021
- NCT04790279Lead sponsorPhase 4Apr 11, 2021
Details
- Last known activity
- Oct 30, 2025